Alzheimer's Disease Drug Discovery Targeted to the APP mRNA 5'Untranslated Region

By Rogers J.T.   Randall J.D.   Eder P.S.   Huang X.   Bush A.I.   Tanzi R.E.   Venti A.   Payton S.M.   Giordano T.   Nagano S.   Cahill C.M.   Moir R.   Lahiri D.K.   Greig N.   Sarang S.S.   Gullans S.R.  

Journal of Molecular Neuroscience, Vol. 19, Iss. 1-2, 2002-10 ,pp. : 77-82

Humana Press, Inc

Access to resources Recommend Favorite

Pilot Study of the Reducing Effect on Amyloidosis In Vivo by Three FDA Pre-Approved Drugs Via the Alzheimer's APP 5'Untranslated Region

By  

Current Alzheimer Research, Vol. 2, Iss. 2, 2005-04 ,pp. : 249-254

Bentham Science Publishers

Access to resources Recommend Favorite

Drug discovery for Alzheimer’s disease: The end of the beginning

By Refolo Lorenzo   Fillit Howard  

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 1-8

Humana Press, Inc

Access to resources Recommend Favorite

RNA Therapeutics Directed to the Non Coding Regions of APP mRNA, In Vivo Anti-Amyloid Efficacy of Paroxetine, Erythromycin, and N-acetyl cysteine

By  

Current Alzheimer Research, Vol. 3, Iss. 3, 2006-07 ,pp. : 221-227

Bentham Science Publishers

Access to resources Recommend Favorite

Drug discovery: Estrogen-related compounds in mouse models of Alzheimer’s disease

By Smith Jonathan   Chakrabarti Enakshi   Levin-Allerhand Justine  

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 145-147

Humana Press, Inc

Access to resources Recommend Favorite